Inflammatory Bowel Disease

Discussing the latest advances in Crohn’s disease and ulcerative colitis

Items Tagged ‘biosimilar’

February 10, 2017

FDA Approves Biosimilar to Humira

By Kanaaz Pereira kanaazpe

The FDA recently approved a biosimilar (trade name, Amjevita) to Humira (adalimumab). A biosimilar is a biological product that is highly similar to the originator drug, and has no clinical differences in terms of safety and effectiveness. Dr. Edward Loftus , M.D., talks about the potential of this drug to offer patients with chronic inflammatory diseases such as Crohn’s and ulcerative colitis an […]

View full entry

Tags: Amjevita, biosimilar, Crohn's disease, Edward Loftus, FDA, Humira, IBD, ulcerative colitis

May 6, 2016

FDA Approves of Biosimilar to Infliximab

By Kanaaz Pereira kanaazpe

The FDA recently approved of a biosimilar (CT-P13) to infliximab, which is used for treating IBD patients, as well as patients suffering from rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis. The new drug would be the first biosimilar monoclonal antibody approved in the United States. Dr. Edward Loftus, M.D., explains how biosimilars work, and discusses […]

View full entry

Tags: biosimilar, CT-P13, Edward Loftus, FDA, IBD, infliximab, rheumatoid arthritis

Contact Us · Privacy Policy